Gupta et al. have demonstrated that on glioma cells [82], IL-1β increased the expression of HLA-G and HMGB1, a ligand of TIM-3, that in turn increases HLA-G on tumor cells upon interaction with another specific receptor, TLR-4 [82]. The gene discussed is HLA-G; the disease is neoplasm.